MAZE
NASDAQ · Pharmaceuticals
Maze Therapeutics Inc
$27.33
+0.41 (+1.52%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-42.72%
1Y
+107.99%
YTD
-31.28%
Open$26.74
Previous Close$26.92
Day High$27.45
Day Low$25.85
52W High$53.65
52W Low$12.81
Volume—
Avg Volume296.7K
Market Cap1.58B
P/E Ratio—
EPS$-2.52
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$42.71
Below
SMA 200
$25.83
Above
RSI (14)
50.1
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
18 analysts
Price Target
+243.6% upside
Current
$27.33
$27.33
Target
$93.90
$93.90
$74.59
$93.90 avg
$145.81
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 190.13M | 546.10M | 525.77M |
| Net Income | 20.86M | 109.70M | 88.79M |
| Profit Margin | 11.0% | 20.1% | 16.9% |
| EBITDA | 69.11M | 173.82M | 160.69M |
| Free Cash Flow | — | 65.89M | 67.30M |
| Rev Growth | — | +21.9% | +7.3% |
| Debt/Equity | — | 0.74 | 0.66 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |